Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -23.24% vs 4.41% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is -1.52% vs 8.20% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 10.04% vs 19.48% in Mar 2025
Compare Balance Sheet Results of Ganga Pharma.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.91
3.00
2.91
97.00%
Share Warrants & Outstandings
Total Reserve
2.40
1.34
1.06
79.10%
Shareholder's Funds
8.31
4.34
3.97
91.47%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.10
0.00
0.10
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.10
0.00
0.10
0.00%
Deferred Tax Assets / Liabilities
0.00
-1.45
1.45
100.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
1.29
-1.29
-100.00%
Long Term Provisions
0.00
0.06
-0.06
-100.00%
Total Non-Current Liabilities
0.10
-0.11
0.21
190.91%
Current Liabilities
Trade Payables
0.12
14.41
-14.29
-99.17%
Other Current Liabilities
0.13
0.70
-0.57
-81.43%
Short Term Borrowings
0.99
0.00
0.99
0.00%
Short Term Provisions
0.00
0.06
-0.06
-100.00%
Total Current Liabilities
1.24
15.17
-13.93
-91.83%
Total Liabilities
9.65
19.40
-9.75
-50.26%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
1.50
1.05
0.45
42.86%
Less: Accumulated Depreciation
0.86
0.69
0.17
24.64%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.65
0.36
0.29
80.56%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.00
0.00
0.00
0.00%
Other Non Current Assets
1.44
1.92
-0.48
-25.00%
Total Non-Current Assets
2.08
2.28
-0.20
-8.77%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
1.17
10.06
-8.89
-88.37%
Sundry Debtors
0.94
3.55
-2.61
-73.52%
Cash and Bank
0.06
0.28
-0.22
-78.57%
Other Current Assets
2.48
0.17
2.31
1,358.82%
Short Term Loans and Advances
2.93
3.06
-0.13
-4.25%
Total Current Assets
7.56
17.12
-9.56
-55.84%
Net Current Assets (Including Current Investments)
6.33
1.95
4.38
224.62%
Total Current Assets Excluding Current Investments
7.56
17.12
-9.56
-55.84%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
9.65
19.40
-9.75
-50.26%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
1.09
0.00
1.09
0.00%
Book Value per share (adjusted)
14.06
14.46
-0.40
-2.77%
Annual - Borrowings
Borrowings 1.09 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -23.24% vs 4.41% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.65 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -1.52% vs 8.20% in Mar 2025
Annual - Investments
Investments 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
Annual - Current Assets
Current Assets 7.56 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 10.04% vs 19.48% in Mar 2025
